Skip to main content

Bionano Genomics, Inc.

BNGO
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001411690

In the last 90 days, Bionano Genomics, Inc. insiders filed 2 open-market purchases and 0 sales; 34 institutions reported holding it in 13F filings for Q2 2026, worth $801.6K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Bionano Genomics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
1 insider, $9.70K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$9.70K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Bionano Genomics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Bionano Genomics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Luderer AlbertInterim Chief Executive8,000IndirectSep 9, 20262
Adamchak MarkPrincipal Accounting Officer253Aug 5, 20264
Dixon Jonathan V.General Counsel239Aug 5, 20264
Oldakowski MarkChief Operating Officer868Aug 5, 20264
Hastie Alex ReidChief Scientific Officer–Aug 5, 20261
Chaubey AlkaCHIEF MEDICAL OFFICER620Jun 3, 20263
Barker David LDirector58,364May 14, 20261
Twomey Christopher JDirector–May 14, 20261
Vuori Kristiina MDDirector–May 14, 20261
Linney YvonneDirector0May 14, 20261
Rajkovic AleksandarDirector–May 14, 20261
Holmlin R. ErikPRESIDENT AND CEO1,657Feb 18, 20262
Mamuszka HannahDirector65,789Jun 12, 20250
Wong Vincent Jung-FaiDirector–Jun 20, 20240
Kama GulsenChief Financial Officer16,000Jun 5, 20240
Stewart Christopher P.Chief Financial Officer281,373May 16, 20230
Shippy RichardChief Business Officer–Feb 15, 20220
Shams SoheilChief Informatics Officer5,325,378Feb 15, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 1, 2021 (view filing)Nov 292 daysHolmlin R. ErikPresident and CEOPPurchase+5.03K$3.99+$20.0KNew position5.03K after3 lots
May 18, 2022 (view filing)May 162 daysBarker David LDirectorPPurchase+10.0K$1.60+$16.0K+256.8%13.9K after
Aug 17, 2022 (view filing)5:55 PM ETAug 152 daysLinney YvonneDirectorSSale−20.0K$3.62−$72.4K−100.0%0 after
May 16, 2023 (view filing)May 124 daysStewart Christopher P.Chief Financial OfficerPPurchase+50.0K$0.67+$33.5K+21.6%281.4K after
May 16, 2023 (view filing)May 16Same dayHolmlin R. ErikPresident and CEOPPurchase+15.0K$0.64+$9.60K+1.9%806.5K after
Jun 14, 2023 (view filing)Jun 131 dayMamuszka HannahDirectorPPurchase+65.8K$0.76+$50.0KNew position65.8K after
Aug 21, 2026 (view filing)4:30 PM ETAug 21Same dayLuderer AlbertInterim Chief ExecutivePPurchase+4.00K$1.22+$4.86KNew position4.00K after
Sep 9, 2026 (view filing)4:30 PM ETSep 45 daysLuderer AlbertInterim Chief ExecutivePPurchase+4.00K$1.21+$4.84K+100.0%8.00K after